Definitive Contract 75F40120C00111

The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $313,326 Firm Fixed Price contract to the University of Wisconsin System, operating through its University of Wisconsin - Madison division. The contract was awarded under a Broad Agency Announcement (BAA) for the "Development of Modernized Acinetobacter Baumannii Susceptibility Guidance for Recommended Antimicrobial Agents Using Pharmacometric Approaches". This contract is not associated with any set-aside designation and was awarded on September 15, 2020, with a completion date of November 30, 2021. The University of Wisconsin System, as a U.S. government entity and 1862 Land Grant College, has a history of conducting federally-funded research and development across various disciplines, including engineering, medicine, and materials science.